Medication info
Rabephia Tablet 10 mg (Rabeprazole Sodium)

Rabephia Tablet 10 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tablet
Manufacturer / importer
HLB Pharmaceuticals Co., Ltd.
Appearance
Pale yellow round enteric-coated tablet
Packaging
28 tablets/box [14 tablets/Alu-Alu*2]
Approval status
Active

MFDS item code 200702534 · Approved 2007.02.28 · Insurance code 647300190

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including combination eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults
Adult dose
Gastric and duodenal ulcers The usual adult oral dose is 10 mg of rabeprazole sodium once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms have resolved, subsequent symptoms may be controlled, as needed, with on-demand therapy using 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients infected with Helicobacter pylori should be treated with an eradication regimen. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome The recommended initial adult dose is 60 mg once daily. The dose may be adjusted according to each patient's needs, up to 120 mg daily. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into two doses of 60 mg each per day. Patients with Zollinger-Ellison syndrome have received this medicine for up to 1 year.

Ingredients

Manufacturer
HLB Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including combination eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcers
  • duodenal ulcers
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcers infected by Helicobacter pylori
  • Zollinger-Ellison syndrome
View approved original text

This medication treats ulcers in the stomach and duodenum, alleviates symptoms of gastroesophageal reflux disease, and is used for long-term maintenance therapy. Additionally, it is used in combination with antibiotics to enhance therapeutic effects in patients with gastrointestinal ulcers infected by Helicobacter pylori. It is also applicable in Zollinger-Ellison syndrome to control excessive gastric acid secretion. This medication is used for the treatment and symptom improvement of various gastrointestinal disorders.

How to take

Adult dose

Gastric and duodenal ulcers The usual adult oral dose is 10 mg of rabeprazole sodium once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms have resolved, subsequent symptoms may be controlled, as needed, with on-demand therapy using 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients infected with Helicobacter pylori should be treated with an eradication regimen. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome The recommended initial adult dose is 60 mg once daily. The dose may be adjusted according to each patient's needs, up to 120 mg daily. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into two doses of 60 mg each per day. Patients with Zollinger-Ellison syndrome have received this medicine for up to 1 year.

Precautions

This medication should not be used in patients with specific allergic reactions. For example, it should not be administered to patients with hypersensitivity to this drug or its components, or to benzimidazole derivatives. Furthermore, patients allergic to specific antibiotics may experience issues when this medication is used in combination. It is safest for pregnant or breastfeeding women to avoid using this medication. In patients with impaired liver function or elderly patients, the side effects of the drug may be more severe; therefore, it should be used with caution. This medication may cause allergic reactions such as skin rash and itching; if such symptoms occur, use should be discontinued immediately. Regular blood tests or liver function tests should be performed, and appropriate action should be taken if abnormal findings are detected. It may affect various bodily systems including the heart, gastrointestinal, and nervous systems; immediate consultation with healthcare professionals is required if any symptoms arise. Long-term use of this medication may increase the risk of fractures, so caution is needed. Additionally, long-term use may lead to electrolyte imbalances such as hypomagnesemia, necessitating periodic testing. This medication suppresses gastric acid secretion, which may increase the risk of bacterial infections in the gastrointestinal tract; if symptoms like diarrhea persist, inform healthcare professionals immediately. Caution is needed while driving or operating machinery as drowsiness may occur. When taken with other medications, interactions may arise, so it is crucial to inform healthcare professionals of any concurrent medications being taken. There is no special antidote for overdose; appropriate treatment should be administered based on symptoms. This medication should be swallowed whole and not chewed or crushed. Keep out of reach of children and avoid transferring to other containers.

Side effects

Rash, urticaria, itching, erythrocyte reduction, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, ALT elevation, AST elevation, ALP elevation, γ-GTP elevation, LDH elevation, total bilirubin elevation, fulminant hepatitis, hepatic dysfunction, jaundice, hypertension, myocardial infarction, ECG abnormalities, migraine, syncope, angina, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, supraventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, blood in stool, anorexia, cholelithiasis, oral ulceration, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stool, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste disorder, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, fatigue, hyperesthesia, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, hypervolemia, upper and lower limb weakness, sensory impairment, decreased grip strength, language confusion, staggering, delusion, spatial disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonic muscle syndrome, neuralgia, single contraction, sweating, alopecia, dry skin, shingles, psoriasis, skin color change, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataracts, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacification, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, urinary difficulty, kidney stones, uterine bleeding, polyuria, breast enlargement, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, orchitis, urinary incontinence, interstitial nephritis, edema, elevated total cholesterol, increased triglycerides, elevated BUN, increased blood thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, fatigue, weight gain, visual disturbances, loss of appetite, neck stiffness, photosensitivity reaction, hangover effect, weight loss, gout, anaphylactic reaction, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, disorientation, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reaction, myalgia, arthralgia, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, erythema multiforme, toxic epidermal necrolysis, mucous membrane syndrome, increased INR, increased prothrombin time, bone fracture, Clostridium difficile associated diarrhea, systemic lupus erythematosus, cutaneous lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature to preserve the drug's efficacy for a longer duration.

Appearance and packaging

Appearance

Pale yellow round enteric-coated tablet

Package unit

28 tablets/box [14 tablets/Alu-Alu*2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.